WeVote
Log In

Bill

Bill

HB 1119

Pharmacy benefit managers; revise provisions related to.

2025 Regular Session Introduced by Chris Bell and 27 co-sponsors

Mississippi bill revising pharmacy benefit manager regulations died in committee without establishing new pricing transparency or access requirements.

Died In Committee
#drugpolicy #stateaffairs
0
WeVote Research Nonpartisan
Bill Summary · HB 1119

Legislative bill overview

HB 1119 proposes revisions to Mississippi's regulations governing pharmacy benefit managers (PBMs)—intermediaries that manage prescription drug benefits for insurance plans. The bill was referred to the Drug Policy and State Affairs committee but died in committee on February 4, 2025, without advancing to a floor vote.

Why is this important

PBMs significantly influence drug pricing, pharmacy access, and medication costs for consumers. Regulatory changes to PBM practices can affect prescription affordability, which directly impacts public health outcomes and healthcare expenses for Mississippi residents and insurers.

Potential points of contention

  • Transparency and pricing: PBMs often face criticism for opaque pricing structures and spread pricing (keeping the difference between reimbursement rates); regulations could require greater disclosure but may increase administrative burden
  • Pharmacy network access: Restrictions on PBM practices could expand pharmacy choice for consumers but might limit insurers' ability to negotiate discounts or manage drug utilization
  • Industry compliance costs: Enhanced regulations could increase operational costs for PBMs, potentially raising insurance premiums or reducing market competition

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.